Agilent Technologies (A) Acquires Proscia to Expand Digital Pathology Capabilities

gurufocus.com · 2026-10-13

On October 13, 2026, Agilent Technologies Inc (NYSE: A) announced the completion of its acquisition of Proscia, a leader in enterprise digital pathology softwar

TickrTrends take: Agilent Technologies' acquisition of Proscia represents a strategic move to strengthen its position in the digital pathology market, an area gaining importance as healthcare providers increasingly adopt digital workflows. With Agilent currently assessed as fairly valued by TickrTrends, investors focused on valuation should monitor whether this acquisition generates sufficient margin expansion or market share gains to justify any integration costs or goodwill that appears on future balance sheets. The effectiveness of this digital pathology expansion in driving revenue growth relative to the company's current valuation multiple will be a key metric to track in upcoming earnings reports.

Read the full story at gurufocus.com →